KDM5A
KDM5A (lysine demethylase 5A, also known as RBBP2 and JARID1A) is a nuclear histone demethylase of the JARID1 family. It removes methyl groups from lysine 4 of histone H3 and regulates gene transcription, including clock-controlled genes. Browse Assay Genie's current range of KDM5A research reagents below, or read on for the biology behind the target.
KDM5A is a histone demethylase that acts specifically on lysine 4 of histone H3 (H3K4), giving it a central role in the histone code. It demethylates trimethylated and dimethylated H3K4 but not the monomethylated form, and it does not act on H3 Lys-9, Lys-27, Lys-36, Lys-79 or H4 Lys-20. Through this activity, and through DNA binding at a 5'-CCGCCC-3' motif, KDM5A regulates specific gene transcription. It may also stimulate transcription mediated by nuclear receptors.
KDM5A also works independently of its demethylase activity. In the circadian clock, it acts as a coactivator of CLOCK-BMAL1-mediated activation of PER1 and PER2 and other clock-controlled genes. It increases histone acetylation at the PER1/2 promoters by inhibiting HDAC1, and it helps maintain the normal periodicity of the clock. For some genes, such as MT1F, it seems to act as a transcriptional corepressor. It is also involved in the transcriptional regulation of Hox proteins during cell differentiation, and it may take part in repressing cytokines such as CXCL12.
The KDM5A gene belongs to the Jumonji, AT-rich interactive domain 1 (JARID1) family, and the protein is found in the nucleus, including the nucleolus. HGNC places it among the PHD finger proteins, the AT-rich interaction domain containing proteins, the EMSY complex and the lysine demethylase 5 family. Earlier names include retinoblastoma-binding protein 2 (RBBP2) and JARID1A, reflecting its interaction with retinoblastoma protein. KDM5A seems to favour the proliferation of cancer cells and may play a role in tumour progression, which makes this KDM5A protein a frequent subject in epigenetics and cancer research.
KDM5A specifically removes di- and trimethyl marks from histone H3 lysine 4, making it a key enzyme for studying the histone code.
KDM5A seems to favour cancer cell proliferation and may play a role in tumour progression, so it is studied as a cancer-related regulator.
KDM5A helps maintain normal clock periodicity by coactivating CLOCK-BMAL1 targets such as PER1 and PER2 and by inhibiting HDAC1.
KDM5A is involved in the transcriptional regulation of Hox proteins during cell differentiation, linking histone demethylation to developmental gene control.
KDM5A is a histone demethylase that removes di- and trimethyl groups from lysine 4 of histone H3, but not the monomethylated form. It regulates transcription through this activity and through DNA binding at 5'-CCGCCC-3' motifs. It also has demethylase-independent roles, including coactivation of circadian clock genes.
KDM5A is also called RBBP2 (retinoblastoma-binding protein 2) and JARID1A. Earlier names include Jumonji, AT rich interactive domain 1A (RBBP2-like) and lysine (K)-specific demethylase 5A. The official HGNC name is lysine demethylase 5A, and the enzyme is classified as EC 1.14.11.67.
NCBI Gene notes that KDM5A may play a role in tumour progression, and UniProt reports that it seems to favour cancer cell proliferation. A mouse ortholog, Kdm5a, exists. Check the datasheet of any product for its validated reactivity.
Other histone lysine demethylases, including the closely related KDM5 member and enzymes acting on different histone marks, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P29375; product specifications from Assay Genie datasheets.